Camilo Camacho

Camilo Camacho serves as COO / Presidente at Procaps Group. Procaps Group operates in the pharmaceuticals sector with approximately 79.0 employees. Procaps Group generates annual revenue of 409920000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,468 c suite-level executives.

Outlook Microsoft Office 365 Microsoft Azure Hosting Microsoft Azure Adobe Marketing Cloud New Relic Bootstrap Framework Kentico Google Tag Manager Google Play YouTube Google Font API ASP.NET Microsoft-IIS reCAPTCHA Mobile Friendly

biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing nutraceuticals otc products prescription drugs clinical solutions health & nutrition innovative health solutions health improvements hospital supplies advanced softgel technology contract development manufacturing services diabetes management chronic condition management quality management system regulatory compliance vertical integration global distribution sustainable practices r&d capabilities medicine manufacturing healthcare solutions nutritional supplements over-the-counter medications quality control clinical specialties community health pharmaceutical formulations health & wellness medical innovation market presence supply chain management employee engagement biopharmaceuticals health technology medication adherence treatment options patient care pharmacy distribution scientific expertise safety standards iso certifications healthcare innovation quality assurance patient support healthcare partnerships market access health wellness & fitness pharmaceuticals medical logistics & supply chain

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Camilo Camacho in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Procaps Group.

Camilo Camacho's Position in the MessageCEO Database

• •Camilo Camacho is 1 of 1 verified executive contact we track at Procaps Group.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •5 verified contacts work at pharmaceuticals companies in the 79.0 employee range (same size as Procaps Group).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Camilo Camacho directly?

Camilo Camacho's verified email address is available to MessageCEO Pro subscribers. They currently serve as COO / Presidente at Procaps Group. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Camilo Camacho work for?

Camilo Camacho is COO / Presidente at Procaps Group, a company in the pharmaceuticals sector with 79.0 employees.

Can I pitch or sell to Camilo Camacho?

As COO / Presidente at Procaps Group, Camilo Camacho is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Camilo Camacho directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Camilo Camacho in?

Camilo Camacho works in the pharmaceuticals industry as COO / Presidente at Procaps Group. MessageCEO provides verified contact information for executives across all major industries.

Is Camilo Camacho's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Camilo Camacho's profile is kept up-to-date with the latest available information.

Last updated: July 30, 2026